Is an albumin-to-creatinine ratio (ACR) of 62 in a random urine sample concerning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is an Albumin-to-Creatinine Ratio of 62 mg/g Concerning?

Yes, an ACR of 62 mg/g is concerning as it indicates moderately increased albuminuria (formerly called microalbuminuria), which signifies kidney damage and substantially increases your risk for both progressive kidney disease and cardiovascular events. 1, 2

Understanding Your Result

Your ACR of 62 mg/g falls into the moderately increased albuminuria category (30-299 mg/g), which represents stage A2 kidney disease. 1 This is not normal—the normal range is defined as less than 30 mg/g creatinine. 1, 2

Clinical Significance

  • Kidney damage marker: This level indicates early kidney damage, even if your kidney function (GFR) appears normal. 1
  • Cardiovascular risk: Even moderately elevated ACR is associated with heightened cardiovascular disease risk, independent of kidney function. 1
  • Progressive risk: At any level of kidney function, increased ACR is associated with higher risk for adverse outcomes, and this risk increases as ACR rises. 2

Confirmation Required Before Diagnosis

You cannot be diagnosed with persistent albuminuria based on a single test. Due to high day-to-day biological variability in urinary albumin excretion, you need 2 out of 3 specimens to be abnormal over a 3-6 month period to confirm true albuminuria. 1, 2

Factors That Can Falsely Elevate ACR

Your result may be temporarily elevated due to: 1

  • Exercise within 24 hours before testing
  • Active infection or fever
  • Congestive heart failure
  • Marked hyperglycemia (very high blood sugar)
  • Menstruation
  • Marked hypertension (very high blood pressure)

Immediate Next Steps

  1. Repeat testing: Obtain 2 additional first morning urine samples for ACR over the next 3-6 months. 2 First morning samples have the lowest variability (31% coefficient of variation). 2

  2. Assess kidney function: If not already done, measure serum creatinine to calculate estimated GFR (eGFR) to determine your kidney function stage. 1

  3. Screen for underlying causes: 1

    • Check blood pressure (hypertension is both a cause and consequence)
    • Screen for diabetes if not already diagnosed
    • Review medications that may affect kidney function

If Confirmed: Treatment Implications

If 2 out of 3 tests over 3-6 months confirm ACR ≥30 mg/g, treatment is indicated: 1

  • Blood pressure control: Target blood pressure should be optimized, typically <130/80 mmHg in the presence of kidney disease. 1
  • ACE inhibitor or ARB therapy: These medications are associated with treatment benefits in adults with increased albuminuria, particularly in the setting of diabetes or cardiovascular disease. 1 They should be titrated to normalize albumin excretion. 1
  • Glycemic control: If diabetic, improved glucose control is essential. 1

Important Caveat for Women of Childbearing Age

ACE inhibitors and ARBs are teratogenic and should be avoided if you are of childbearing age without reliable contraception. 1 Reproductive counseling is essential before starting these medications. 1

Monitoring Frequency

  • If confirmed: ACR and eGFR should be monitored at least every 6 months, or more frequently depending on your overall risk profile and response to treatment. 2
  • Annual monitoring minimum: Even with treatment, annual assessment is recommended for anyone with confirmed kidney disease. 1

Risk Stratification

Your ACR of 62 mg/g, combined with your kidney function (GFR), determines your overall risk for progression to kidney failure. 1 The combination of these two parameters guides the intensity of monitoring and treatment. Even if your GFR is currently normal (≥90 mL/min/1.73 m²), the presence of moderately increased albuminuria moves you from stable disease (A1/G1) to a higher risk category requiring closer follow-up. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Use of Creatinine in Albumin-to-Creatinine Ratio for Kidney Damage Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.